TMDX Oct 2024 190.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 09:39AM EDT
Loading interactive chart...
- Simply Wall St.
TransMedics Group, Inc. (NASDAQ:TMDX) About To Shift From Loss To Profit
We feel now is a pretty good time to analyse TransMedics Group, Inc.'s ( NASDAQ:TMDX ) business as it appears the...
- PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on June 18, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 1,002 shares of its common stock and an aggregate of 657 restricted stock units to 1 employee, each as a material inducement for the employee's entry into employment with TransMedics. The grants
- Zacks
TransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
© 2024 Yahoo. All rights reserved.